DIN EN ISO 13408-6 E 2019-05 PDF

Full title and description

STB DIN EN ISO 13408-6 E 2019-05 — Aseptic processing of health care products — Part 6: Isolator systems. This document is the European/DIN designation of the ISO work on isolator systems used in aseptic manufacture and provides requirements and guidance on design, selection, qualification, bio‑decontamination, validation, operation and control of isolator systems for aseptic processing of health care products.

Abstract

This standard (designation E 2019-05) focuses on isolator systems as a separation technology to protect the critical processing zone during aseptic production. It covers the principles for establishing and maintaining a controlled isolator environment, risks from viable and non‑viable particulates, validated bio‑decontamination processes (often automated), glove‑port interventions and aspects of operator/product separation. Note: the 2019 European/DIN designation was later superseded by the consolidated ISO/DIN edition published in 2021.

General information

• Status: Withdrawn / superseded (European/DIN adoption dated May 2019; later superseded by the ISO/DIN edition published in 2021).
• Publication date: 01 May 2019 (designation E 2019-05).
• Publisher: Deutsches Institut für Normung (DIN) — European adoption of the ISO document.
• ICS / categories: 11.080.01 — Sterilization and disinfection in general.
• Edition / version: E DIN EN ISO 13408-6:2019-05 (European/DIN adoption of the ISO draft/publication stream). Superseded by DIN EN ISO 13408-6:2021-11.
• Number of pages: Publication listings for the 2019 adoption indicate a longer technical document (listed as ~90 pages in some catalogues for the 2019 adoption); later consolidated 2021 editions are listed with shorter page counts in national catalogues. Users should check the specific edition they intend to purchase for exact pagination.

Scope

The standard specifies requirements and gives guidance for isolator systems used in aseptic processing of health care products. Topics include specification and selection of isolator systems, qualification and validation approaches, methods and control of bio‑decontamination, routine operation and monitoring, interfaces with facility systems, and risk‑based controls to ensure product sterility. It does not replace national regulatory requirements (e.g., GMP) and does not cover biosafety containment requirements; restricted access barrier systems (RABS) are treated separately or excluded where noted.

Key topics and requirements

• Definition and classification of isolator systems and their intended uses.
• Specification and selection criteria for isolator hardware and interfaces (glove‑ports, transfer systems, pass‑throughs).
• Qualification and validation strategies, including installation/operational/performance qualification (IQ/OQ/PQ) and process verification.
• Bio‑decontamination: validated agents, automated cycles, cycle design, and residual control.
• Environmental and process monitoring, particulate and microbiological control, and alarm/response requirements.
• Risk assessment and integration with GMP, documentation, change control and supplier requirements.
• Operational procedures for maintenance, glove changes/repairs, personnel interactions (minimized via barrier design) and cleaning.

Typical use and users

Primary users include pharmaceutical and biotech manufacturers performing aseptic filling and processing, manufacturers of parenteral and sterile medical devices, contract manufacturing organizations (CMOs), validation and quality assurance engineers, facility designers, and regulatory/compliance teams responsible for sterile production. The standard is used when specifying isolator systems, defining validation protocols, designing production lines, or auditing aseptic operations.

Related standards

ISO 13408 is a multi‑part series; related parts include filtration (Part 2), lyophilization (Part 3), CIP (Part 4), SIP (Part 5) and other parts covering aseptic qualification. Other related standards and guidance: ISO 13408‑1…‑7 series, ISO 18362 (cell‑based product microbial control), ISO 17665 (moist heat sterilization) and regionally applicable GMP/compendial chapters (e.g., relevant USP chapters). The 2019/DIN adoption was later incorporated into the consolidated 2021 edition of ISO 13408‑6.

Keywords

aseptic processing, isolator systems, isolator qualification, bio‑decontamination, validation, sterile manufacturing, glove‑ports, cleanroom interfaces, risk assessment, GMP alignment.

FAQ

Q: What is this standard?

A: It is the European/DIN designation of ISO 13408‑6 (E 2019‑05) addressing isolator systems used in the aseptic processing of health care products — providing requirements and guidance for specification, qualification, bio‑decontamination and operation of isolators.

Q: What does it cover?

A: It covers design and selection criteria for isolator systems, validation and qualification approaches (IQ/OQ/PQ), validated bio‑decontamination methods, environmental and process monitoring, operational controls, and risk‑based integration with GMP. It excludes some containment/biosafety topics and does not replace national regulatory requirements.

Q: Who typically uses it?

A: Pharmaceutical and biotech manufacturers, medical device producers for sterile products, CMOs, QA/RA and validation engineers, equipment suppliers and facility designers involved in aseptic manufacturing.

Q: Is it current or superseded?

A: The DIN/EN ISO designation dated 01 May 2019 (E 2019‑05) was recorded in national catalogues but has been superseded by the later consolidated ISO/DIN edition published in 2021 (ISO 13408‑6:2021 / DIN EN ISO 13408‑6:2021‑11). Users should refer to the 2021 edition for the current international text and check national adoption status before purchase or compliance work.

Q: Is it part of a series?

A: Yes — ISO 13408 is a multipart series on aseptic processing of health care products (Parts 1–7 cover general requirements, filtration, lyophilization, CIP, SIP, isolator systems and aseptic qualification of solids/devices).

Q: What are the key keywords?

A: Isolator systems, aseptic processing, bio‑decontamination, validation, glove‑ports, sterile filling, qualification, GMP, environmental monitoring.